Colon
-
Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Phase 2 · randomised · 353 people · 6 sites in Netherlands · Recruiting now
-
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Phase 3 · randomised · 386 people · 1 site in China · Recruiting now
-
Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer
Phase 3 · randomised · 1,660 people · 1 site in France · Recruiting now
-
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Phase 2 · 100 people · 11 sites in United States · Recruiting now
-
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Phase 2 · 140 people · 48 sites in 8 countries · Recruiting now
-
Safety of HRX215 in Patients After Minor and Major Liver Resection
Phase 2 · randomised · 80 people · 12 sites in 5 countries · Recruiting now